FES detects ER available to bind estrogen ligand, thus FES PET/CT is indicated only for patients with known ER-positive BC.12 Patients with ER-negative BC are unlikely to have their disease detected by FES PET, were excluded from this study, and should not be considered for FES PET/CT.17 Here, ESR1 is linked to breast cancer.